Ricardo Salvador

Ricardo Salvador

Auto-generated profile, based on publicly available information

Ricardo Salvador

Research Department, Neuroelectrics Barcelona, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2013 in NeuroImage
Verified
Journal Article
Closed access
PMPedro Cavaleiro Miranda
Pedro Cavaleiro Miranda
AMAbeye Mekonnen
Abeye Mekonnen
RSRicardo Salvador
Ricardo Salvador
Giulio RuffiniGiulio Ruffini
Giulio Ruffini

4 September 2012 in IEEE Transactions on Neural Systems and Rehabilitation Engineering
Verified
Journal Article
Closed access
Giulio RuffiniGiulio Ruffini
Giulio Ruffini
FWFabrice Wendling
Fabrice Wendling
IMIsabelle Merlet
Isabelle Merlet
BMBehnam Molaee-Ardekani
Behnam Molaee-Ardekani
AMAbeye Mekonnen
Abeye Mekonnen
PMPedro C. Miranda
Pedro C. Miranda
In this paper, we provide a broad overview of models and technologies pertaining to transcranial current brain stimulation (tCS), a family of related noninvasive techniques including direct current (tDCS), alternating current (tACS), and random noise current stimulation (tRNS). These techniques are based on the delivery of weak currents through the scalp (with electrode current intensity to area ratios of about 0.3-5 A/m 2 ) at low frequencies (typically <; 1 kHz) resulting in weak electric fields in the brain (with amplitudes of about 0.2-2 V/m). Here we review the biophysics and simulation of noninvasive, current-controlled generation of electric fields in the human brain and the models for the interaction of these electric fields with neurons, including a survey of in vitro and in vivo related studies. Finally, we outline directions for future fundamental and technological research.

1 August 2017 in NeuroImage
Verified
Journal Article
Closed access
DFDavid Fischer
David Fischer
PFP.J. Fried
P.J. Fried
GRG. Ruffini
G. Ruffini
ORO. Ripolles
O. Ripolles
RSR. Salvador
R. Salvador
MFM D Fox
M D Fox


8 July 2014 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
PMPedro C Miranda
Pedro C Miranda
AMAbeye Mekonnen
Abeye Mekonnen
RSRicardo Salvador
Ricardo Salvador
PBPeter J Basser
Peter J Basser
The use of alternating electric fields has been recently proposed for the treatment of recurrent glioblastoma. In order to predict the electric field distribution in the brain during the application of such tumor treating fields (TTF), we constructed a realistic head model from MRI data and placed transducer arrays on the scalp to mimic an FDA-approved medical device. Values for the tissue dielectric properties were taken from the literature; values for the device parameters were obtained from the manufacturer. The finite element method was used to calculate the electric field distribution in the brain. We also included a 'virtual lesion' in the model to simulate the presence of an idealized tumor. The calculated electric field in the brain varied mostly between 0.5 and 2.0 V cm( - 1) and exceeded 1.0 V cm( - 1) in 60% of the total brain volume. Regions of local field enhancement occurred near interfaces between tissues with different conductivities wherever the electric field was perpendicular to those interfaces. These increases were strongest near the ventricles but were also present outside the tumor's necrotic core and in some parts of the gray matter-white matter interface. The electric field values predicted in this model brain are in reasonably good agreement with those that have been shown to reduce cancer cell proliferation in vitro. The electric field distribution is highly non-uniform and depends on tissue geometry and dielectric properties. This could explain some of the variability in treatment outcomes. The proposed modeling framework could be used to better understand the physical basis of TTF efficacy through retrospective analysis and to improve TTF treatment planning.

9 September 2015 in Physics in Medicine & Biology
Verified
Journal Article
Open access
PDF file
CWCornelia Wenger
Cornelia Wenger
RSRicardo Salvador
Ricardo Salvador
PBPeter J Basser
Peter J Basser
PMPedro C Miranda
Pedro C Miranda
Tumor treating fields (TTFields) are a non-invasive, anti-mitotic and approved treatment for recurrent glioblastoma multiforme (GBM) patients. In vitro studies have shown that inhibition of cell division in glioma is achieved when the applied alternating electric field has a frequency in the range of 200 kHz and an amplitude of 1-3 V cm(-1). Our aim is to calculate the electric field distribution in the brain during TTFields therapy and to investigate the dependence of these predictions on the heterogeneous, anisotropic dielectric properties used in the computational model. A realistic head model was developed by segmenting MR images and by incorporating anisotropic conductivity values for the brain tissues. The finite element method (FEM) was used to solve for the electric potential within a volume mesh that consisted of the head tissues, a virtual lesion with an active tumour shell surrounding a necrotic core, and the transducer arrays. The induced electric field distribution is highly non-uniform. Average field strength values are slightly higher in the tumour when incorporating anisotropy, by about 10% or less. A sensitivity analysis with respect to the conductivity and permittivity of head tissues shows a variation in field strength of less than 42% in brain parenchyma and in the tumour, for values within the ranges reported in the literature. Comparing results to a previously developed head model suggests significant inter-subject variability. This modelling study predicts that during treatment with TTFields the electric field in the tumour exceeds 1 V cm(-1), independent of modelling assumptions. In the future, computational models may be useful to optimize delivery of TTFields.